Lawrence Fong, MD | Authors


Inducing an Immune Response With a Patient’s Tumor

September 18, 2014

Lawrence Fong, MD, discusses the systemic antitumor effect and clinical response in a phase II trial of intratumoral electroporation of plasmid interleukin-12 (IL-12) in patients with advanced melanoma.

Memory T Cell Responses Following Anti-CTLA-4 Antibody Treatment

July 17, 2014

Lawrence Fong, MD, associate professor, Department of Medicine (Hematology/Oncology), University of California, San Francisco, discusses research to examine the immunobiology and biomarkers associated with improved clinical outcomes seen during treatment with an anti-CTLA-4 antibody.